Navigation Links
Elsevier announces launch of new journal: Current Opinion in Insect Science
Date:7/14/2014

New York, July 14, 2014 How does oxygen control insect body size? What influence does genetics have on insects' social structure? Articles published in the first issue of Current Opinion in Insect Science launched today aims to answer these and more questions.

Current Opinion in Insect Science is the latest title in Elsevier's Current Opinion journal series. It is a review journal that aims to provide specialists with a unique platform to keep uptodate with the expanding volume of information published in the field of insect science. First articles published are now available for free on ScienceDirect.

Professor David Denlinger (Ohio State University, Columbus, OH, USA) and Dr. Jeff Harvey (Netherlands Institute of Ecology) lead the editorial board.

"Initially I was reluctant to launch a new journal as there are so many out there already," said Denlinger. "I soon realized the unique niche defined by Elsevier's Current Opinion series however. This addition to the series offers an exciting way to keep the growing community of insect scientists up to date on diverse hot topics affecting our field."

"Following the success of the Molecular Insect Science conference held in Amsterdam in 2011, we started to develop the idea of a new Current Opinion title that could encompass the expanding amount of research in the insect science discipline," said Dale Seaton, Executive Publisher Biological Sciences at Elsevier. "With David and Jeff's leadership we have assembled a series of topical reviews from the world's leading scientists that will provide essential reading updates for the insect research community."


'/>"/>

Contact: Jason Awerdick
j.awerdick@elsevier.com
212-633-3103
Elsevier
Source:Eurekalert

Page: 1

Related biology news :

1. Elsevier Announces the launch of open access journal: New Negatives in Plant Science
2. Elsevier announces the launch of a new journal: Current Opinion in Behavioral Sciences
3. Elsevier publish CBS-KNAW Fungal Biodiversity Centre official journal Studies in Mycology
4. Elsevier selected publish official journal: Engineering in Agriculture, Environment & Food
5. Elsevier journal Translational Proteomics endorsed by the Human Proteome Organization
6. Elsevier announces the launch of a new journal: Geoderma Regional
7. Elsevier announces the launch of OA journal: Colloid and Interface Science Communications
8. Elsevier and Energy Institute work together to publish Journal of the Energy Institute
9. Elsevier announces the launch of open access journal: Pathogenesis
10. Elsevier announces the launch of open access journal: Current Plant Biology
11. Elseviers Biochimica et Biophysica Acta (BBA) journal series adds open access journal: BBA Clinical
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... -- First quarter 2016:   , Revenues ... first quarter of 2015 The gross margin was 49% ... and the operating margin was 40% (-13) Earnings per ... from operations was SEK 249.9 M (21.2) , Outlook ... 7,000-8,500 M. The operating margin for 2016 is estimated ...
(Date:4/15/2016)... -- Research and Markets has announced the ...  report to their offering.  ,      ... gait biometrics market is expected to grow at ... Gait analysis generates multiple variables such ... compute factors that are not or cannot be ...
(Date:3/29/2016)... Florida , March 29, 2016 ... the "Company") LegacyXChange "LEGX" and SelectaDNA/CSI Protect are pleased ... in ink used in a variety of writing instruments, ... Buyers of originally created collectibles from athletes on LegacyXChange ... forensic analysis of the DNA. Bill ...
Breaking Biology News(10 mins):
(Date:6/24/2016)... Brooklyn, NY (PRWEB) , ... June 24, 2016 , ... ... 15mm, machines such as the Cary 5000 and the 6000i models are higher end ... height is the height of the spectrophotometer’s light beam from the bottom of the ...
(Date:6/23/2016)... , June 23, 2016 /PRNewswire/ - FACIT ... Ontario biotechnology company, Propellon Therapeutics ... development and commercialization of a portfolio of first-in-class ... Epigenetic targets such as WDR5 represent an exciting ... significantly in precision medicine for cancer patients. Substantial ...
(Date:6/23/2016)... June, 23, 2016  The Biodesign Challenge (BDC), a ... ways to harness living systems and biotechnology, announced its ... in New York City . ... students, showcased projects at MoMA,s Celeste Bartos Theater during ... , MoMA,s senior curator of architecture and design, and ...
(Date:6/23/2016)... 2016 Apellis Pharmaceuticals, Inc. today announced ... of its complement C3 inhibitor, APL-2. The trials ... dose studies designed to assess the safety, tolerability, ... in healthy adult volunteers. Forty subjects ... single dose (ranging from 45 to 1,440mg) or ...
Breaking Biology Technology: